Stockreport

Asahi Kasei Pharma Strengthens Preclinical Pipeline Through Exclusive Global License Agreement with Alchemedicine for Novel Lead Compounds [Yahoo! Finance]

ASAHI KAISEI CRP UNSP/ADR  (AHKSY) 
NASDAQ:AMEX Investor Relations: asahi-kasei.co.jp/asahi/en/ir
PDF Asahi Kasei's Tokyo Headquarters TOKYO, February 25, 2026 BUSINESS WIRE Asahi Kasei Pharma announced that it has strengthened its drug discovery pipeline through an e [Read more]